Skip to content

Added to your cart:

Cart subtotal

Cleocin Phosphate Clindamycin Injection 900 mg Per mL 6 mL (150mg) x 25/Box (RX)

SKU 00009-0902-18
Sale 10%
Original price $ 199.95
Current price $ 179.00
In stock
Non-Returnable
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 10%
Original price $ 199.95
Current price $ 179.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Cleocin Phosphate Clindamycin Injection 900 mg Per mL 6 mL (150mg) x 25/Box (RX)
Cleocin Phosphate Clindamycin Injection 900 mg Per mL 6 mL (150mg) x 25/Box (RX)
$ 199.95 $ 179.00
🔒 Medical License Required
Description
Product Overview
Specifications
Clinical/Professional Use
Safety & Contraindications
Ordering, Licensing & Shipping
Disclaimer
FAQ

Cleocin Phosphate Clindamycin Injection is an antibiotic medication used to treat serious bacterial infections. It comes in a vial containing 6 mL and has a concentration of 150 mg/mL. Each box contains 25 vials. It is primarily used for the treatment of infections such as pneumonia, skin and soft tissue infections, and bone infections. It works by stopping the growth of bacteria that cause these infections. This medication should only be administered under the supervision of a healthcare professional.

There are several benefits for using Pfizer USPG Cleocin Phosphate Clindamycin Injection:

  • Effective Treatment for Bacterial Infections: This medication is prescribed to treat severe bacterial infections, including pneumonia, skin infections, and blood infections. It belongs to the category of antibiotics known as lincosamides, and it works by inhibiting the growth of bacteria.
  • Flexible Dosing Options: This medication is available in different strengths (150mg/mL and 300mg/mL) and sizes (6mL and 25mL). This allows doctors to tailor the dosage according to an individual's specific medical condition, ensuring effective treatment with minimum risk of side effects.
  • Quick Action: Due to its injectable form, it gets absorbed into the bloodstream quickly, allowing for a faster onset of action compared to oral medications. This can be especially useful in cases where a patient needs immediate treatment for a severe infection.
  • Convenient Administration: Cleocin Phosphate is administered intravenously by a healthcare professional, making it an easy option for patients who cannot take oral medications due to nausea/vomiting or those who may have trouble swallowing pills.
  • Reliable Antimicrobial: Clindamycin has been used as an antimicrobial agent for decades, making it well-studied and considered safe by most healthcare professionals.
  • Approved by FDA: Pfizer USPG Cleocin Phosphate Clindamycin Injection is approved by the Food and Drug Administration (FDA), indicating its safety and efficacy.
  • Potential Cost Savings: Pfizer USPG Cleocin Phosphate Clindamycin Injection is available in generic form, which could mean cost savings compared to brand-name medications.
  • Product: Cleocin Phosphate (Clindamycin Phosphate) Injection, 150 mg/mL- Pfizer USPG
  • NDC: 00009-0902-18
  • Format: 6 mL single-dose vials, 25 vials per box (900 mg clindamycin phosphate per vial)
  • Drug class: Lincosamide antibiotic - bacteriostatic; inhibits bacterial protein synthesis via 50S ribosomal subunit binding
  • Approval status: FDA-approved; prescription (RX) required for purchase and use
  • Primary indications: Serious bacterial infections including pneumonia, septicemia, skin and soft tissue infections, intra-abdominal infections, and bone and joint infections caused by susceptible organisms
  • Intended buyers: Licensed healthcare professionals, clinics, hospitals, EMS teams, and institutional purchasing departments
Attribute Detail
Brand Name Cleocin Phosphate
Generic Name Clindamycin Phosphate
Manufacturer Pfizer USPG
NDC Number 00009-0902-18
Concentration 150 mg/mL
Vial Volume 6 mL per vial
Dose per Vial 900 mg clindamycin phosphate
Box Quantity 25 vials per box
Route of Administration Intravenous (IV) or Intramuscular (IM) - must be diluted for IV use
Vial Type Single-dose
Regulatory Status FDA-approved; Prescription (RX) only
Drug Class Lincosamide antibiotic
  • Serious lower respiratory tract infections: Including pneumonia and lung abscess caused by anaerobes, streptococci, staphylococci, and pneumococci susceptible to clindamycin
  • Skin and soft tissue infections: Including cellulitis, wound infections, and necrotising fasciitis involving susceptible gram-positive and anaerobic organisms
  • Septicemia: Caused by susceptible staphylococci and streptococci; often used as part of combination therapy
  • Intra-abdominal infections: Peritonitis and intra-abdominal abscess — typically used in combination with a gram-negative agent given clindamycin's limited aerobic gram-negative coverage
  • Female pelvic and genital tract infections: Including endometritis, pelvic inflammatory disease, and post-surgical infections involving anaerobes
  • Bone and joint infections: Including acute hematogenous osteomyelitis caused by Staphylococcus aureus; clindamycin achieves good bone penetration
  • Clinical note: Susceptibility testing is required prior to use, particularly for MRSA isolates — inducible resistance (D-zone positive) precludes clindamycin use regardless of initial disk diffusion results

This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.

  • Black Box Warning - C. difficile-Associated Diarrhea (CDAD): Clindamycin has been associated with severe and potentially fatal colitis caused by Clostridioides difficile. CDAD must be considered in any patient presenting with diarrhea during or after clindamycin therapy. Discontinue use if CDAD is suspected or confirmed.
  • Hypersensitivity reactions: Serious reactions including anaphylaxis and severe skin reactions have been reported. Discontinue immediately if a severe allergic reaction occurs. Do not use in patients with known hypersensitivity to clindamycin or lincomycin.
  • IV administration requirements: Must be diluted before intravenous infusion. Do not administer as an IV bolus. Infusion rate must not exceed 30 mg/minute - rapid infusion is associated with hypotension and cardiorespiratory arrest.
  • Use with caution: In patients with a history of gastrointestinal disease (particularly colitis), hepatic impairment, or atopic conditions. Monitor liver function in prolonged courses.
  • Neuromuscular blockade: Clindamycin has neuromuscular blocking properties and may potentiate the effects of other neuromuscular blocking agents - use with care in patients receiving such agents.
  • Prescription only: This product is for use by or under the supervision of a licensed healthcare professional. Not for consumer purchase or self-administration.

This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.

  • Prescription required: Cleocin Phosphate Clindamycin Injection is a prescription-only (RX) product. Valid medical licensing documentation is required to complete purchase. Mountainside Medical verifies credentials prior to order fulfilment.
  • Eligible buyers: Licensed clinics, hospitals, physician offices, EMS providers, dental practices, veterinary practices, medspas with appropriate licensure, and institutional purchasing departments
  • Wholesale pricing: Priced for bulk and high-volume procurement. Volume-based savings are available - contact the sales team to confirm current pricing for your facility type and order quantity.
  • New account discount: New customers receive 5% off their first purchase
  • Shipping: Free shipping on orders over $100 across the continental United States. Contact sales to confirm cold chain and temperature-controlled shipping requirements for this product.
  • Contact sales: Phone: +1 (888) 687-4334 | Email: sales@mountainside-medical.com

Cleocin Phosphate (Clindamycin Phosphate) Injection is a prescription-only (RX) pharmaceutical product regulated under U.S. federal law. It may only be dispensed by or upon the order of a licensed healthcare professional. This product is not for consumer purchase or personal use.

The clinical information provided on this page - including indications, dosing references, mechanism of action, and safety information - is intended for use by qualified healthcare professionals only. It is provided for informational and procurement reference purposes and does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information issued by Pfizer USPG.

All prescribers and administering clinicians must review the complete Pfizer USPG Cleocin Phosphate prescribing information, including contraindications, warnings, drug interactions, and dosing instructions, before clinical use. Dosing and administration must be individualised based on patient-specific clinical factors and current clinical guidelines.

Mountainside Medical Equipment is a wholesale medical supply distributor and is not responsible for clinical outcomes associated with the use of this product. All clinical decisions remain the sole responsibility of the treating licensed healthcare professional.

This page references NDC 00009-0902-18 and manufacturer information as provided at the time of listing. Product availability, pricing, and specifications are subject to change. Contact Mountainside Medical sales for current availability confirmation before order placement.

  • Is Cleocin the same as clindamycin?

    Yes. Cleocin is the brand name; clindamycin phosphate is the generic name for the same active compound. Pfizer USPG manufactures the branded Cleocin Phosphate injectable. Generic versions of clindamycin phosphate injection contain the same active ingredient at equivalent concentrations and are FDA-approved as therapeutically equivalent to the brand.

  • What is the generic name for Cleocin Phosphate injection?

    The generic name is clindamycin phosphate. The phosphate ester form is used specifically for the injectable formulation — it is a prodrug that is hydrolysed in the body to the active compound, clindamycin. When ordering generically, specify clindamycin phosphate injection to distinguish it from topical or oral clindamycin formulations.

  • What is the standard clindamycin IV dose for adults?

    Per Pfizer USPG prescribing information, the standard adult IV dose for serious infections is 600 to 900 mg every 8 hours, administered by infusion — not IV push. At 900 mg per 6 mL vial, a single vial of this product provides one full standard high-dose adult dose. More serious infections may require higher total daily doses; consult the full prescribing information and apply clinical judgement based on infection severity, site, and causative organism.

  • What is the clindamycin 900 mg IV infusion rate?

    The maximum infusion rate is 30 mg/minute. A 900 mg dose should be infused over a minimum of 30 minutes. Clindamycin must be diluted in a compatible IV solution prior to infusion and must never be administered as an undiluted IV bolus — rapid infusion has been associated with hypotension and cardiorespiratory adverse events.

  • What infections is Cleocin Phosphate injection used to treat?

    FDA-approved indications for Cleocin Phosphate injection include serious infections caused by susceptible anaerobes and susceptible strains of streptococci, pneumococci, and staphylococci. These include lower respiratory tract infections such as pneumonia and lung abscess, serious skin and soft tissue infections, septicemia, intra-abdominal infections, female pelvic and genital tract infections, and bone and joint infections including osteomyelitis.

  • Can I purchase Cleocin Phosphate injection without a prescription?

    No. Cleocin Phosphate Clindamycin Injection is a prescription-only product under U.S. federal law. Purchase through Mountainside Medical requires valid medical licensing documentation. Eligible buyers include licensed physicians, clinics, hospitals, EMS providers, and other credentialled healthcare facilities. Contact the sales team to confirm your facility's eligibility prior to placing an order.

  • What is the NDC number for this product?

    The NDC number for Pfizer USPG Cleocin Phosphate Clindamycin Injection 150 mg/mL, 6 mL vial, 25-count box is 00009-0902-18. Use this number when verifying product identity, submitting purchase orders, or confirming formulary listings.

  • What is the difference between the 150 mg/mL and 300 mg/mL clindamycin injection concentrations?

    Both concentrations contain the same active ingredient — clindamycin phosphate — and are pharmacologically equivalent. The 150 mg/mL concentration in this product comes in a 6 mL vial delivering 900 mg per vial. The 300 mg/mL concentration is available in larger vial volumes. The choice between them is logistical rather than clinical: the 150 mg/mL format suits single high-dose administration from one vial, while higher concentrations may simplify dilution calculations in certain facility workflows. Contact Mountainside Medical sales to discuss which format best suits your facility's usage patterns.

  • Does Mountainside Medical offer wholesale pricing on Cleocin Phosphate injection?

    Yes. Mountainside Medical supplies this product at wholesale pricing for licensed healthcare professionals and institutional buyers. Volume-based pricing is available. New accounts receive 5% off their first purchase. Free shipping applies on orders over $100 within the continental United States. For current pricing on this SKU and volume discount tiers, contact the sales team at +1 (888) 687-4334 or sales@mountainside-medical.com.

Description

Cleocin Phosphate Clindamycin Injection is an antibiotic medication used to treat serious bacterial infections. It comes in a vial containing 6 mL and has a concentration of 150 mg/mL. Each box contains 25 vials. It is primarily used for the treatment of infections such as pneumonia, skin and soft tissue infections, and bone infections. It works by stopping the growth of bacteria that cause these infections. This medication should only be administered under the supervision of a healthcare professional.

There are several benefits for using Pfizer USPG Cleocin Phosphate Clindamycin Injection:

  • Effective Treatment for Bacterial Infections: This medication is prescribed to treat severe bacterial infections, including pneumonia, skin infections, and blood infections. It belongs to the category of antibiotics known as lincosamides, and it works by inhibiting the growth of bacteria.
  • Flexible Dosing Options: This medication is available in different strengths (150mg/mL and 300mg/mL) and sizes (6mL and 25mL). This allows doctors to tailor the dosage according to an individual's specific medical condition, ensuring effective treatment with minimum risk of side effects.
  • Quick Action: Due to its injectable form, it gets absorbed into the bloodstream quickly, allowing for a faster onset of action compared to oral medications. This can be especially useful in cases where a patient needs immediate treatment for a severe infection.
  • Convenient Administration: Cleocin Phosphate is administered intravenously by a healthcare professional, making it an easy option for patients who cannot take oral medications due to nausea/vomiting or those who may have trouble swallowing pills.
  • Reliable Antimicrobial: Clindamycin has been used as an antimicrobial agent for decades, making it well-studied and considered safe by most healthcare professionals.
  • Approved by FDA: Pfizer USPG Cleocin Phosphate Clindamycin Injection is approved by the Food and Drug Administration (FDA), indicating its safety and efficacy.
  • Potential Cost Savings: Pfizer USPG Cleocin Phosphate Clindamycin Injection is available in generic form, which could mean cost savings compared to brand-name medications.
Product Overview
  • Product: Cleocin Phosphate (Clindamycin Phosphate) Injection, 150 mg/mL- Pfizer USPG
  • NDC: 00009-0902-18
  • Format: 6 mL single-dose vials, 25 vials per box (900 mg clindamycin phosphate per vial)
  • Drug class: Lincosamide antibiotic - bacteriostatic; inhibits bacterial protein synthesis via 50S ribosomal subunit binding
  • Approval status: FDA-approved; prescription (RX) required for purchase and use
  • Primary indications: Serious bacterial infections including pneumonia, septicemia, skin and soft tissue infections, intra-abdominal infections, and bone and joint infections caused by susceptible organisms
  • Intended buyers: Licensed healthcare professionals, clinics, hospitals, EMS teams, and institutional purchasing departments
Specifications
Attribute Detail
Brand Name Cleocin Phosphate
Generic Name Clindamycin Phosphate
Manufacturer Pfizer USPG
NDC Number 00009-0902-18
Concentration 150 mg/mL
Vial Volume 6 mL per vial
Dose per Vial 900 mg clindamycin phosphate
Box Quantity 25 vials per box
Route of Administration Intravenous (IV) or Intramuscular (IM) - must be diluted for IV use
Vial Type Single-dose
Regulatory Status FDA-approved; Prescription (RX) only
Drug Class Lincosamide antibiotic
Clinical/Professional Use
  • Serious lower respiratory tract infections: Including pneumonia and lung abscess caused by anaerobes, streptococci, staphylococci, and pneumococci susceptible to clindamycin
  • Skin and soft tissue infections: Including cellulitis, wound infections, and necrotising fasciitis involving susceptible gram-positive and anaerobic organisms
  • Septicemia: Caused by susceptible staphylococci and streptococci; often used as part of combination therapy
  • Intra-abdominal infections: Peritonitis and intra-abdominal abscess — typically used in combination with a gram-negative agent given clindamycin's limited aerobic gram-negative coverage
  • Female pelvic and genital tract infections: Including endometritis, pelvic inflammatory disease, and post-surgical infections involving anaerobes
  • Bone and joint infections: Including acute hematogenous osteomyelitis caused by Staphylococcus aureus; clindamycin achieves good bone penetration
  • Clinical note: Susceptibility testing is required prior to use, particularly for MRSA isolates — inducible resistance (D-zone positive) precludes clindamycin use regardless of initial disk diffusion results

This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.

Safety & Contraindications
  • Black Box Warning - C. difficile-Associated Diarrhea (CDAD): Clindamycin has been associated with severe and potentially fatal colitis caused by Clostridioides difficile. CDAD must be considered in any patient presenting with diarrhea during or after clindamycin therapy. Discontinue use if CDAD is suspected or confirmed.
  • Hypersensitivity reactions: Serious reactions including anaphylaxis and severe skin reactions have been reported. Discontinue immediately if a severe allergic reaction occurs. Do not use in patients with known hypersensitivity to clindamycin or lincomycin.
  • IV administration requirements: Must be diluted before intravenous infusion. Do not administer as an IV bolus. Infusion rate must not exceed 30 mg/minute - rapid infusion is associated with hypotension and cardiorespiratory arrest.
  • Use with caution: In patients with a history of gastrointestinal disease (particularly colitis), hepatic impairment, or atopic conditions. Monitor liver function in prolonged courses.
  • Neuromuscular blockade: Clindamycin has neuromuscular blocking properties and may potentiate the effects of other neuromuscular blocking agents - use with care in patients receiving such agents.
  • Prescription only: This product is for use by or under the supervision of a licensed healthcare professional. Not for consumer purchase or self-administration.

This product is intended for use by qualified healthcare professionals or under the guidance of a licensed medical provider. It is not a substitute for professional medical advice, diagnosis, or treatment.

Ordering, Licensing & Shipping
  • Prescription required: Cleocin Phosphate Clindamycin Injection is a prescription-only (RX) product. Valid medical licensing documentation is required to complete purchase. Mountainside Medical verifies credentials prior to order fulfilment.
  • Eligible buyers: Licensed clinics, hospitals, physician offices, EMS providers, dental practices, veterinary practices, medspas with appropriate licensure, and institutional purchasing departments
  • Wholesale pricing: Priced for bulk and high-volume procurement. Volume-based savings are available - contact the sales team to confirm current pricing for your facility type and order quantity.
  • New account discount: New customers receive 5% off their first purchase
  • Shipping: Free shipping on orders over $100 across the continental United States. Contact sales to confirm cold chain and temperature-controlled shipping requirements for this product.
  • Contact sales: Phone: +1 (888) 687-4334 | Email: sales@mountainside-medical.com
Disclaimer

Cleocin Phosphate (Clindamycin Phosphate) Injection is a prescription-only (RX) pharmaceutical product regulated under U.S. federal law. It may only be dispensed by or upon the order of a licensed healthcare professional. This product is not for consumer purchase or personal use.

The clinical information provided on this page - including indications, dosing references, mechanism of action, and safety information - is intended for use by qualified healthcare professionals only. It is provided for informational and procurement reference purposes and does not constitute medical advice, clinical guidance, or a substitute for the full prescribing information issued by Pfizer USPG.

All prescribers and administering clinicians must review the complete Pfizer USPG Cleocin Phosphate prescribing information, including contraindications, warnings, drug interactions, and dosing instructions, before clinical use. Dosing and administration must be individualised based on patient-specific clinical factors and current clinical guidelines.

Mountainside Medical Equipment is a wholesale medical supply distributor and is not responsible for clinical outcomes associated with the use of this product. All clinical decisions remain the sole responsibility of the treating licensed healthcare professional.

This page references NDC 00009-0902-18 and manufacturer information as provided at the time of listing. Product availability, pricing, and specifications are subject to change. Contact Mountainside Medical sales for current availability confirmation before order placement.

FAQ
  • Is Cleocin the same as clindamycin?

    Yes. Cleocin is the brand name; clindamycin phosphate is the generic name for the same active compound. Pfizer USPG manufactures the branded Cleocin Phosphate injectable. Generic versions of clindamycin phosphate injection contain the same active ingredient at equivalent concentrations and are FDA-approved as therapeutically equivalent to the brand.

  • What is the generic name for Cleocin Phosphate injection?

    The generic name is clindamycin phosphate. The phosphate ester form is used specifically for the injectable formulation — it is a prodrug that is hydrolysed in the body to the active compound, clindamycin. When ordering generically, specify clindamycin phosphate injection to distinguish it from topical or oral clindamycin formulations.

  • What is the standard clindamycin IV dose for adults?

    Per Pfizer USPG prescribing information, the standard adult IV dose for serious infections is 600 to 900 mg every 8 hours, administered by infusion — not IV push. At 900 mg per 6 mL vial, a single vial of this product provides one full standard high-dose adult dose. More serious infections may require higher total daily doses; consult the full prescribing information and apply clinical judgement based on infection severity, site, and causative organism.

  • What is the clindamycin 900 mg IV infusion rate?

    The maximum infusion rate is 30 mg/minute. A 900 mg dose should be infused over a minimum of 30 minutes. Clindamycin must be diluted in a compatible IV solution prior to infusion and must never be administered as an undiluted IV bolus — rapid infusion has been associated with hypotension and cardiorespiratory adverse events.

  • What infections is Cleocin Phosphate injection used to treat?

    FDA-approved indications for Cleocin Phosphate injection include serious infections caused by susceptible anaerobes and susceptible strains of streptococci, pneumococci, and staphylococci. These include lower respiratory tract infections such as pneumonia and lung abscess, serious skin and soft tissue infections, septicemia, intra-abdominal infections, female pelvic and genital tract infections, and bone and joint infections including osteomyelitis.

  • Can I purchase Cleocin Phosphate injection without a prescription?

    No. Cleocin Phosphate Clindamycin Injection is a prescription-only product under U.S. federal law. Purchase through Mountainside Medical requires valid medical licensing documentation. Eligible buyers include licensed physicians, clinics, hospitals, EMS providers, and other credentialled healthcare facilities. Contact the sales team to confirm your facility's eligibility prior to placing an order.

  • What is the NDC number for this product?

    The NDC number for Pfizer USPG Cleocin Phosphate Clindamycin Injection 150 mg/mL, 6 mL vial, 25-count box is 00009-0902-18. Use this number when verifying product identity, submitting purchase orders, or confirming formulary listings.

  • What is the difference between the 150 mg/mL and 300 mg/mL clindamycin injection concentrations?

    Both concentrations contain the same active ingredient — clindamycin phosphate — and are pharmacologically equivalent. The 150 mg/mL concentration in this product comes in a 6 mL vial delivering 900 mg per vial. The 300 mg/mL concentration is available in larger vial volumes. The choice between them is logistical rather than clinical: the 150 mg/mL format suits single high-dose administration from one vial, while higher concentrations may simplify dilution calculations in certain facility workflows. Contact Mountainside Medical sales to discuss which format best suits your facility's usage patterns.

  • Does Mountainside Medical offer wholesale pricing on Cleocin Phosphate injection?

    Yes. Mountainside Medical supplies this product at wholesale pricing for licensed healthcare professionals and institutional buyers. Volume-based pricing is available. New accounts receive 5% off their first purchase. Free shipping applies on orders over $100 within the continental United States. For current pricing on this SKU and volume discount tiers, contact the sales team at +1 (888) 687-4334 or sales@mountainside-medical.com.

Get Notified When Back in Stock